A prospective combination of phase II and phase III in drug development (Q478229): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
Importer (talk | contribs)
Changed an Item
Property / author
 
Property / author: Adelchi Azzalini / rank
 
Normal rank
Property / Mathematics Subject Classification ID
 
Property / Mathematics Subject Classification ID: 62P10 / rank
 
Normal rank
Property / Mathematics Subject Classification ID
 
Property / Mathematics Subject Classification ID: 62L05 / rank
 
Normal rank
Property / zbMATH DE Number
 
Property / zbMATH DE Number: 6376448 / rank
 
Normal rank
Property / zbMATH Keywords
 
adaptive designs
Property / zbMATH Keywords: adaptive designs / rank
 
Normal rank
Property / zbMATH Keywords
 
conditional power
Property / zbMATH Keywords: conditional power / rank
 
Normal rank
Property / zbMATH Keywords
 
drug development
Property / zbMATH Keywords: drug development / rank
 
Normal rank
Property / zbMATH Keywords
 
likelihood-based inference
Property / zbMATH Keywords: likelihood-based inference / rank
 
Normal rank
Property / zbMATH Keywords
 
skew-normal distribution
Property / zbMATH Keywords: skew-normal distribution / rank
 
Normal rank

Revision as of 18:32, 30 June 2023

scientific article
Language Label Description Also known as
English
A prospective combination of phase II and phase III in drug development
scientific article

    Statements

    A prospective combination of phase II and phase III in drug development (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    3 December 2014
    0 references
    adaptive designs
    0 references
    conditional power
    0 references
    drug development
    0 references
    likelihood-based inference
    0 references
    skew-normal distribution
    0 references

    Identifiers